# Gefitinib

NDC: 0480-4053
Generic name: Gefitinib
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230621

FDA application: ANDA208913

## Active ingredients

- GEFITINIB: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-4053"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-4053
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3dd135f0-5db1-4236-9756-04533b66dc9d